Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias (Q46119160)
Jump to navigation
Jump to search
scientific article published on 17 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias |
scientific article published on 17 February 2009 |
Statements
1 reference
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias (English)
1 reference
1 reference
Ken Shiozawa
1 reference
Ming Tan
1 reference
Hong-Bin Fang
1 reference
Wen-chyi Wang
1 reference
Martin J Edelman
1 reference
David Carlton
1 reference
Ivana Gojo
1 reference
Edward A Sausville
1 reference
Douglas D Ross
1 reference
17 February 2009
1 reference
15
1 reference
5
1 reference
1698-1707
1 reference